These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9123696)

  • 1. Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management.
    Solsona E; Iborra I; Ricós JV; Dumont R; Casanova JL; Calabuig C
    Urology; 1997 Mar; 49(3):347-52. PubMed ID: 9123696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prostate involvement as prognostic factor in patients with superficial bladder tumors.
    Solsona E; Iborra I; Ricós JV; Monrós JL; Casanova JL; Almenar S
    J Urol; 1995 Nov; 154(5):1710-3. PubMed ID: 7563328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.
    Wright JL; Hotaling J; Porter MP
    J Urol; 2009 Mar; 181(3):1035-9; discussion 1039. PubMed ID: 19150569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors.
    Takayanagi A; Masumori N; Takahashi A; Takagi Y; Tsukamoto T
    Int J Urol; 2012 Mar; 19(3):229-33. PubMed ID: 22121922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper tract tumors in patients with primary bladder cancer followed for 15 years.
    Herr HW; Cookson MS; Soloway SM
    J Urol; 1996 Oct; 156(4):1286-7. PubMed ID: 8808855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter.
    Kenworthy P; Tanguay S; Dinney CP
    J Urol; 1996 Feb; 155(2):501-3. PubMed ID: 8558645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Four cases of upper urinary tract transitional cell carcinoma after radical cystectomy in bladder cancer].
    Nishio Y; Kaku S; Hida S; Ohishi K; Okada Y; Yoshida O
    Hinyokika Kiyo; 1988 Sep; 34(9):1593-9. PubMed ID: 3213794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
    Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavior of urothelial carcinoma with respect to anatomical location.
    Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC
    J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.
    Tran W; Serio AM; Raj GV; Dalbagni G; Vickers AJ; Bochner BH; Herr H; Donat SM
    J Urol; 2008 Jan; 179(1):96-100. PubMed ID: 17997449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
    Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
    J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.